A股異動丨西部牧業(300106.SZ)復牌延續一字漲停 擬購買天山廣和100%股權
格隆匯6月2日丨西部牧業(300106.SZ)復牌延續一字漲停,報8.59元,已經連續三日漲停,總市值18億元。西部牧業(300106.SZ)公佈,公司擬以發行股份方式購買天山軍墾、石河子國資公司合計持有的天山廣和100%股權,天山廣和100%股權的預估值和初步交易作價尚未確定。本次交易完成後,上市公司將持有天山廣和100%股權。本次發行股份購買資產的股份發行價格為5.96元/股。本次交易完成後,上市公司將實現對飼料生產與銷售、奶牛養殖與生鮮乳供給、乳製品加工與銷售等產業鏈的打通與融合,有利於幫助上市公司把握行業發展機遇,加快佔領市場份額和行業整合。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.